<DOC>
	<DOCNO>NCT02107807</DOCNO>
	<brief_summary>Evaluate safety , immune response reactogenicity aH5N1 vaccination adult ( 18 60 year age ) elderly ( â‰¥61 year age ) subject without immunosuppressive condition .</brief_summary>
	<brief_title>Safety Immunogenicity Two Doses aH5N1 Vaccine Adult Elderly Subjects With Without Immunosuppressive Conditions *aH5N1 : Monovalent H5N1 Influenza Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Influenza Birds</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<mesh_term>Lactitol</mesh_term>
	<criteria>Male female individual 18 year age old time enrollment mentally competent , willing able understand nature risk propose study , able sign consent form prior study entry ; Individuals able comply study procedures requirement ; Healthy volunteer volunteer specifically HIV positive , transplant recipient , cancer patient may eligible ; Please contact site additional eligibility criterion . Individuals able follow require study procedure whole period study ; Individuals behavioral cognitive impairment psychiatric disease , opinion Investigator , may interfere subject 's ability participate study ; Please contact site additional eligibility criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Influenza ,</keyword>
	<keyword>H5N1</keyword>
	<keyword>aH5N1</keyword>
	<keyword>H5N1 vaccine</keyword>
	<keyword>Pandemic Influenza vaccine</keyword>
	<keyword>MF59</keyword>
	<keyword>Adjuvant</keyword>
	<keyword>Avian flu</keyword>
	<keyword>Underlying Immunosuppressive</keyword>
	<keyword>immunosuppressive condition</keyword>
	<keyword>Pandemic vaccine</keyword>
	<keyword>Adjuvanted vaccine</keyword>
</DOC>